19
1
49
7
8
a
1b
1d
18
79
34
1d
2 29
1d
25
34
Warren B. Bilker, Ph.D.
93Professor of Biostatistics in Biostatistics and Epidemiology at the Hospital of the University of Pennsylvania
7
75
Department: Biostatistics and Epidemiology
4
1
23
1f
Graduate Group Affiliations
8
a
b
1d
46
Contact information
5a
4
3
3
1d
5a
Department of Biostatistics and Epidemiology
3e University of Pennsylvania Perelman School of Medicine
4d 601 Blockley Hall, 423 Guardian Drive
Philadelphia, PA 19104-6021
26
3e University of Pennsylvania Perelman School of Medicine
4d 601 Blockley Hall, 423 Guardian Drive
Philadelphia, PA 19104-6021
2e
Office: 215-898-1619
32 Fax: 215-573-4865
24
81
32 Fax: 215-573-4865
24
Email:
WARREN@UPENN.EDU
12
WARREN@UPENN.EDU
18
Publications
23 a
3
2
4
b
1f
23 a
13
Education:
21 9 B.A. 18 (Mathematics) c
2a Temple University, 1981.
21 9 M.S. 17 (Statistics) c
2a Temple University, 1984.
21 a Ph.D. 1a (Biostatistics) c
31 Johns Hopkins University, 1992.
c
3
27
21 9 B.A. 18 (Mathematics) c
2a Temple University, 1981.
21 9 M.S. 17 (Statistics) c
2a Temple University, 1984.
21 a Ph.D. 1a (Biostatistics) c
31 Johns Hopkins University, 1992.
c
Links
97 Search PubMed for articles
d
5
3
3
8b
Permanent link97 Search PubMed for articles
d
2 29
21
1e
1d
24
7
29
27
23
19f Miller CJ, Conroy A, Bilker WB, Stephens-Shields AJ, Farrar JT: The impact of opioid withdrawal symptoms on pain outcomes in enriched enrollment randomized withdrawal trials: a mediation meta-analysis of trials submitted to the US Food and Drug Administration. Pain Dec 2025 Notes: DOI: 10.1097/j.pain.0000000000003895. Online ahead of print.
125 Hsu YS, Thakrar AP, Leonard CE, Lowenstein M, Brensinger CM, Bilker WB, Bogar KF, Hennessy S: Trends in Methadone Use for Pain and Opioid Use Disorder Among Medicaid Enrollees. JAMA Health Forum 6(11): e255023, Nov 2025.
1b3 Miller CJ, Bilker WB, DeLorey I, Argoff CE, Bell RL, Conroy A, Gewandter JS, Gilron I, Haythornthwaite JA, Katz NP, McWilliams T, Theken KN, Farrar JT: Minimum clinically important differences in acute pain: a patient-level re-analysis of randomized controlled analgesic trials submitted to the US Food and Drug Administration. Pain 166(10): 2430-2438, Oct 2025.
18b Kamsheh AM, Bilker WB, Huang Y, Okunowo O, Burstein DS, Edelson JB, Lin KY, Maeda K, Mavroudis CD, O'Connor MJ, Wittlieb-Weber CA, Bogner HR, Rossano JW: Prolonged Inotrope Use After Surgery for Congenital Heart Disease: A Common Occurrence with a High Burden of Mortality. Pediatric Cardiology 46(7): 2037-2046, Oct 2025.
127 Srivastava T, Harris RA, Bettigole C, Zhang H, Brensinger CM, Bogar K, Wang F, Nesoff ED, Bilker WB, Hennessy S : Stimulant Overdose Prediction Model for Medicaid-Insured Persons. JAMA Health forum 6(9): e253489, Sep 2025.
168 Wang H, MacDonald ML, Borgmann-Winter KE, Banerjee A, Sleiman P, Tom A, Khan A, Lee K, Roussos P, Siegel SJ, Hemby SE, Bilker WB, Gur RE, Hahn C: Retraction Note: mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia. Molecular Psychiatry 30(7): 3358, Jul 2025.
1ab Conroy A, Bilker WB, Miller CJ, Argoff CE, Bell R, Haythornthwaite J, Gewandter JS, Gilron I, Theken KN, Farrar JT : Predictors of successful initiation of buprenorphine in enriched enrollment randomized withdrawal clinical trials in both opioid experienced and naïve participants: a participant-level meta-analysis. Pain Reports 10(4): e1281, Jun 2025.
110 Loabile B, Bilker WB, Khunou K, Ngwako N, Tsima B, Brooks MJ, Moloi T, Morroni C, Gross R : Association of HIV status with infections complicating abortion in Botswana. AIDS 39(7): 923-926, Jun 2025.
1e1 Shivji S, Mannathoko N, Mosepele M, Gross R, Cressman L, Jaskowiak-Barr A, Bilker WB, Alby K, Glaser L, Richard-Greenblatt M, Cowden L, Patel A, Sewawa K, Otukile D, Paganotti GM, Mokomane M, Snitkin E, Lautenbach E: Risk factors for household colonization by extended-spectrum cephalosporin-resistant enterobacterales (ESCrE) in Botswana. Antimicrobial Resistance and Infection Control 14(1): 58, May 2025.
2c
7
1d
1f
Selected Publications
19a Conroy A, Bilker WB, DeLorey I, Chudnovskaya D, McWilliams T, Miller CJ, Argoff CE, Bell R, Gewandter JS, Gilron I, Haythornthwaite J, Theken KN, Farrar JT: Predictors of response to full agonist opioids in enriched enrollment randomized withdrawal clinical trials: a participant-level data meta-analysis. Pain 167(2): 320-325, Feb 2026.19f Miller CJ, Conroy A, Bilker WB, Stephens-Shields AJ, Farrar JT: The impact of opioid withdrawal symptoms on pain outcomes in enriched enrollment randomized withdrawal trials: a mediation meta-analysis of trials submitted to the US Food and Drug Administration. Pain Dec 2025 Notes: DOI: 10.1097/j.pain.0000000000003895. Online ahead of print.
125 Hsu YS, Thakrar AP, Leonard CE, Lowenstein M, Brensinger CM, Bilker WB, Bogar KF, Hennessy S: Trends in Methadone Use for Pain and Opioid Use Disorder Among Medicaid Enrollees. JAMA Health Forum 6(11): e255023, Nov 2025.
1b3 Miller CJ, Bilker WB, DeLorey I, Argoff CE, Bell RL, Conroy A, Gewandter JS, Gilron I, Haythornthwaite JA, Katz NP, McWilliams T, Theken KN, Farrar JT: Minimum clinically important differences in acute pain: a patient-level re-analysis of randomized controlled analgesic trials submitted to the US Food and Drug Administration. Pain 166(10): 2430-2438, Oct 2025.
18b Kamsheh AM, Bilker WB, Huang Y, Okunowo O, Burstein DS, Edelson JB, Lin KY, Maeda K, Mavroudis CD, O'Connor MJ, Wittlieb-Weber CA, Bogner HR, Rossano JW: Prolonged Inotrope Use After Surgery for Congenital Heart Disease: A Common Occurrence with a High Burden of Mortality. Pediatric Cardiology 46(7): 2037-2046, Oct 2025.
127 Srivastava T, Harris RA, Bettigole C, Zhang H, Brensinger CM, Bogar K, Wang F, Nesoff ED, Bilker WB, Hennessy S : Stimulant Overdose Prediction Model for Medicaid-Insured Persons. JAMA Health forum 6(9): e253489, Sep 2025.
168 Wang H, MacDonald ML, Borgmann-Winter KE, Banerjee A, Sleiman P, Tom A, Khan A, Lee K, Roussos P, Siegel SJ, Hemby SE, Bilker WB, Gur RE, Hahn C: Retraction Note: mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia. Molecular Psychiatry 30(7): 3358, Jul 2025.
1ab Conroy A, Bilker WB, Miller CJ, Argoff CE, Bell R, Haythornthwaite J, Gewandter JS, Gilron I, Theken KN, Farrar JT : Predictors of successful initiation of buprenorphine in enriched enrollment randomized withdrawal clinical trials in both opioid experienced and naïve participants: a participant-level meta-analysis. Pain Reports 10(4): e1281, Jun 2025.
110 Loabile B, Bilker WB, Khunou K, Ngwako N, Tsima B, Brooks MJ, Moloi T, Morroni C, Gross R : Association of HIV status with infections complicating abortion in Botswana. AIDS 39(7): 923-926, Jun 2025.
1e1 Shivji S, Mannathoko N, Mosepele M, Gross R, Cressman L, Jaskowiak-Barr A, Bilker WB, Alby K, Glaser L, Richard-Greenblatt M, Cowden L, Patel A, Sewawa K, Otukile D, Paganotti GM, Mokomane M, Snitkin E, Lautenbach E: Risk factors for household colonization by extended-spectrum cephalosporin-resistant enterobacterales (ESCrE) in Botswana. Antimicrobial Resistance and Infection Control 14(1): 58, May 2025.
2c